

Brief Overview of Statement to the FDA: SCN8A Families Support for New Disease Altering Medications
Sharing the SCN8A lived experience with the Food and Drug Administration to stress the urgent need for targeted treatments.
Brief Overview of Statement to the FDA: SCN8A Families Support for New Disease Altering Medications